[Form 4] Accenture PLC Insider Trading Activity
Accenture plc (ACN) Form 4: Atsushi Egawa, listed as Co-CEO Asia Pacific and an officer of Accenture, reported a transaction dated 08/15/2025. The filing shows a grant of restricted share units (RSUs) issued pursuant to anti-dilution provisions tied to previously granted RSU awards to reflect Accenture's cash dividend. The reported transaction lists Class A ordinary shares related to the RSU grant and indicates an acquisition event. The form was signed by an attorney-in-fact on 08/18/2025. The filing discloses direct and indirect holdings, including shares held by an immediate family member.
- RSU grant reported under anti-dilution provisions to preserve award value after a cash dividend
- Officer disclosure (Co-CEO Asia Pacific) filed the Form 4, showing compliance with Section 16 reporting
- None.
Insights
TL;DR: Insider received RSUs tied to anti-dilution for a dividend; this is a routine compensation adjustment, not a market-moving change.
The Form 4 documents a compensatory equity grant rather than a market purchase or sale. The grant stems from anti-dilution provisions of prior RSU awards to account for a company cash dividend, which preserves the economic value of outstanding awards. For investors, this reflects standard equity plan mechanics and does not by itself indicate a change in executive intent or firm performance. The transaction date is 08/15/2025 and the filing was executed 08/18/2025.
TL;DR: This is an administrative RSU grant under existing plan terms; it aligns with typical governance practices for dividend treatment on equity awards.
The disclosure notes the grant was made pursuant to anti-dilution provisions to reflect Accenture's dividend payment. Such adjustments are common to maintain award value and are expected under well-structured equity compensation plans. The reporting person is an officer (Co-CEO Asia Pacific), and both direct and indirect holdings are disclosed, including family-held shares, satisfying standard transparency requirements under Section 16.